title: Lack of Cost-Effectiveness Analyses to Address Healthy People 2020 Priority Areas.
abstract: OBJECTIVE
  To examine the extent to which recently published cost-utility analyses (cost-effectiveness analyses using quality-adjusted life-years to measure health benefits) have covered the leading health concerns in the US Department of Health and Human Services Healthy People 2020 report.
  
  
  METHODS
  We examined data in the Tufts Medical Center Cost-Effectiveness Analysis Registry, a database containing 5000 published cost-utility analyses published in the MEDLINE literature through 2014. We focused on US-based cost-utility analyses published from 2011 through 2014 (n = 687). Two reviewers scanned abstracts and met for a consensus on categorization of cost-utility analyses that addressed the specific priorities listed in the 12 Healthy People 2020 areas (n = 120).
  
  
  RESULTS
  Although 7.3% of recently published cost-utility analyses addressed key clinical preventive services, only about 2% of recently published cost-utility analyses covered each of the following Healthy People 2020 topics: reproductive and sexual health, nutrition/physical activity/obesity, maternal and infant health, and tobacco. Fewer than 1% addressed priorities such as injuries and violence, mental health or substance abuse, environmental quality, and oral health.
  
  
  CONCLUSIONS
  Few cost-utility analyses have addressed Healthy People 2020 priority areas.
authors.affiliation: At the time this work was conducted, Peter J. Neumann, Megan Farquhar, Colby L. Wilkinson, and Mackenzie Lowry were with the Center for the Evaluation of Value and Risk in Health, Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA. Marthe Gold was with the New York Academy of Medicine, New York, NY.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Neumann
authors.affiliation: At the time this work was conducted, Peter J. Neumann, Megan Farquhar, Colby L. Wilkinson, and Mackenzie Lowry were with the Center for the Evaluation of Value and Risk in Health, Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA. Marthe Gold was with the New York Academy of Medicine, New York, NY.
authors.forename: Megan
authors.initials: M
authors.lastname: Farquhar
authors.affiliation: At the time this work was conducted, Peter J. Neumann, Megan Farquhar, Colby L. Wilkinson, and Mackenzie Lowry were with the Center for the Evaluation of Value and Risk in Health, Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA. Marthe Gold was with the New York Academy of Medicine, New York, NY.
authors.forename: Colby L
authors.initials: CL
authors.lastname: Wilkinson
authors.affiliation: At the time this work was conducted, Peter J. Neumann, Megan Farquhar, Colby L. Wilkinson, and Mackenzie Lowry were with the Center for the Evaluation of Value and Risk in Health, Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA. Marthe Gold was with the New York Academy of Medicine, New York, NY.
authors.forename: Mackenzie
authors.initials: M
authors.lastname: Lowry
authors.affiliation: At the time this work was conducted, Peter J. Neumann, Megan Farquhar, Colby L. Wilkinson, and Mackenzie Lowry were with the Center for the Evaluation of Value and Risk in Health, Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA. Marthe Gold was with the New York Academy of Medicine, New York, NY.
authors.forename: Marthe
authors.initials: M
authors.lastname: Gold
mesh_terms: D003362:Cost-Benefit Analysis; D005260:Female; D006292:Health Priorities; D006301:Health Services Needs and Demand; D040361:Healthy People Programs / Q000191:economics*; D006801:Humans; D008297:Male; D012042:Registries